BIO:VIR
Vir Biotechnology
- Stock
Last Close
6.95
22/11 21:00
Market Cap
1.14B
Beta: -
Volume Today
891.72K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 4.30M - | 4.30M 0% | ||||||
average payables | 5.69M - | 6.18M 8.64% | 5.48M 11.30% | 5.80M 5.84% | 6.47M 11.60% | 6.38M 1.44% | ||
average receivables | 386.54M - | 386.54M 0% | ||||||
book value per share | -0.71 - | -1.85 159.99% | 13.97 855.52% | 6.02 56.93% | 11.02 83.25% | 15.67 42.15% | 0.01 99.92% | |
capex per share | -0.03 - | -0.08 198.76% | -0.29 248.47% | -0.05 81.34% | -0.17 205.63% | -0.51 205.41% | -0.00 99.97% | |
capex to depreciation | -6.35 - | -2.97 53.17% | -1.98 33.41% | -1.20 39.20% | -3.75 211.98% | -10.03 167.13% | -1.11 88.94% | |
capex to operating cash flow | 0.04 - | 0.09 110.76% | 0.07 20.79% | 0.03 50.27% | 0.46 1,236.63% | -0.04 108.92% | 0.03 167.73% | |
capex to revenue | -18.40 - | -9.44 48.72% | -12.57 33.23% | -0.10 99.23% | -0.02 79.39% | -0.04 114.47% | -0.25 481.57% | |
cash per share | 1.94 - | 1.02 47.61% | 12.63 1,143.74% | 6.18 51.05% | 5.45 11.83% | 18.11 232.24% | 0.01 99.94% | |
days of inventory on hand | 47.62 - | |||||||
days payables outstanding | -241.09 - | 36.14 - | 16.02 55.67% | 836.13 5,119.31% | ||||
days sales outstanding | 259.57 - | |||||||
debt to assets | 1.17 - | 1.69 45.28% | 0.00 99.97% | 0.08 16,466.69% | 0.07 8.25% | 0.05 35.08% | 0.06 27.41% | |
debt to equity | -4.26 - | -1.81 57.44% | 0.00 100.03% | 0.10 17,478.63% | 0.10 2.29% | 0.06 35.86% | 0.07 14.03% | |
dividend yield | ||||||||
earnings yield | -0.05 - | -0.09 65.90% | -0.46 436.43% | -0.09 79.54% | 0.10 203.85% | 0.15 58.13% | -0.00 100.30% | |
enterprise value | 1.17B - | 1.31B 11.99% | 272.70M 79.20% | 2.82B 934.48% | 5.22B 85.18% | 2.64B 49.55% | 1.35T 51,091.51% | |
enterprise value over ebitda | -14.44 - | -11.31 21.70% | -1.53 86.45% | -9.50 519.96% | 18.48 294.53% | 2.79 84.89% | -1.97K 70,734.35% | |
ev to operating cash flow | -17.64 - | -13.93 21.00% | -2.10 84.90% | -14.77 602.32% | -109.77 642.99% | 1.58 101.44% | -1.73K 109,429.84% | |
ev to sales | 7.86K - | 1.51K 80.78% | 383.55 74.61% | 41.95 89.06% | 4.81 88.55% | 1.67 65.30% | 15.66K 938,711.26% | |
free cash flow per share | -0.71 - | -1.06 47.98% | -4.57 332.59% | -1.66 63.70% | -0.53 67.76% | 12.03 2,351.22% | -0.01 100.05% | |
free cash flow yield | -0.05 - | -0.08 47.98% | -0.36 382.10% | -0.06 82.95% | -0.01 79.38% | 0.48 3,824.17% | -0.00 100.12% | |
graham net net | -1.37 - | -2.81 105.43% | 9.73 446.26% | 4.49 53.86% | 5.93 32.02% | 12.65 113.48% | 0.01 99.93% | |
graham number | 3.40 - | 7.05 107.68% | 42.53 503.04% | 18.42 56.69% | 31.77 72.49% | 37.03 16.56% | 0.03 99.91% | |
income quality | 0.95 - | 0.81 14.56% | 0.74 8.61% | 0.64 13.85% | -0.09 114.08% | 3.22 3,681.40% | 1.27 60.73% | |
intangibles to total assets | 0.21 - | 0.28 33.87% | 0.10 63.43% | 0.06 46.25% | 0.03 53.48% | 0.02 31.00% | 0.02 16.07% | |
interest coverage | 4.55 - | |||||||
interest debt per share | 3.03 - | 3.35 10.65% | 0.01 99.77% | 0.59 7,470.72% | 1.06 79.05% | 2.35 121.64% | 0.00 99.96% | |
inventory turnover | 7.66 - | |||||||
invested capital | -4.26 - | -1.81 57.44% | 0.00 100.03% | 0.10 17,478.63% | 0.10 2.29% | 0.06 35.86% | 0.07 14.03% | |
market cap | 1.36B - | 1.36B 0% | 381.80M 71.90% | 3.19B 735.80% | 5.44B 70.42% | 3.36B 38.28% | 1.35T 40,103.98% | |
net current asset value | -128.13M - | -252.99M 97.44% | 314.87M 224.46% | 570.46M 81.17% | 1.04B 82.38% | 1.79B 72.52% | 1.26B 29.84% | |
net debt to ebitda | 2.32 - | 0.41 82.29% | 0.61 49.31% | 1.25 103.26% | -0.76 160.83% | -0.76 0.71% | 0.21 127.41% | |
net income per share | -0.72 - | -1.20 65.90% | -5.76 381.34% | -2.51 56.45% | 4.07 262.37% | 3.89 4.41% | -0.00 100.12% | |
operating cash flow per share | -0.68 - | -0.97 41.75% | -4.27 339.91% | -1.60 62.48% | -0.37 77.13% | 12.54 3,523.30% | -0.01 100.05% | |
payables turnover | -1.51 - | 10.10 - | 22.78 125.57% | 0.44 98.08% | ||||
receivables turnover | 1.41 - | |||||||
research and ddevelopement to revenue | 419.54 - | 115.47 72.48% | 208.82 80.84% | 4.50 97.85% | 0.41 90.84% | 0.30 27.13% | 6.84 2,178.34% | |
return on tangible assets | -0.35 - | -0.84 139.38% | -0.38 54.81% | -0.34 9.50% | 0.28 180.68% | 0.19 32.49% | -0.33 274.61% | |
revenue per share | 0.00 - | 0.01 482.55% | 0.02 161.56% | 0.56 2,308.90% | 8.37 1,383.09% | 11.92 42.40% | 0.00 99.99% | |
roe | 1.01 - | 0.65 36.19% | -0.41 163.71% | -0.42 1.11% | 0.37 188.61% | 0.25 32.76% | -0.39 255.81% | |
roic | -0.31 - | -0.81 158.80% | -0.42 48.33% | -0.35 17.12% | 0.16 144.94% | 0.24 56.43% | -0.39 257.51% | |
sales general and administrative to revenue | 145.59 - | 33.56 76.95% | 52.88 57.56% | 1.05 98.01% | ||||
shareholders equity per share | -0.71 - | -1.85 159.99% | 13.97 855.52% | 6.02 56.93% | 11.02 83.25% | 15.67 42.15% | 0.01 99.92% | |
stock based compensation to revenue | 32.09 - | 5.82 81.86% | 12.26 110.65% | 0.41 96.65% | 0.08 81.22% | 0.06 16.20% | 1.29 1,899.81% | |
tangible asset value | -121.73M - | -233.03M 91.42% | 371.31M 259.34% | 666.10M 79.39% | 1.38B 107.42% | 2.03B 46.80% | 1.55B 23.54% | |
tangible book value per share | -1.26 - | -2.40 91.42% | 12.23 608.80% | 5.59 54.31% | 10.64 90.29% | 15.30 43.79% | 0.01 99.92% | |
working capital | 179.91M - | 77.88M 56.71% | 343.79M 341.46% | 673.30M 95.85% | 1.22B 81.43% | 2.01B 64.38% | 1.41B 29.64% |
All numbers in (except ratios and percentages)